Teduglutide smpc
WebApr 5, 2024 · Inclusion Criteria: Diagnosis of SBS defined as intestinal resection for congenital or acquired intestinal disease leading to dependence on PS for 90 days. Received teduglutide after FDA approval. Age ≥ 1 years and ≤ 18 years at start of teduglutide initiation. Weight ≥ 10 kg at start of teduglutide initiation. WebGattex (teduglutide) is a member of the miscellaneous GI agents drug class and is commonly used for Short Bowel Syndrome. The cost for Gattex subcutaneous kit 5 mg is around $1,794 for a supply of 1 kits, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans.
Teduglutide smpc
Did you know?
WebFeb 9, 2024 · Orphan Register. Updated 3 February 2024. Orphan registered products are listed in alphabetical order by trade name. The list may be searched by pressing “CTRL+F” and entering a key word or ... Web(teduglutide [rDNA origin]) for injection is a glucagon-like months. If clinically meaningful changes are seen, further evaluation is peptide-2 (GLP-2) analog indicated for the …
WebFor research use only. Teduglutide (ALX-0600, Gattex, Revestive, TAK 633) is an analogue of human glucagon-like peptide-2 (GLP-2) and binds to the GLP-2 receptors. Teduglutide prolongs the intestinotrophic properties of GLP-2 in animal models. CAS No. 197922-42-2. WebJan 12, 2024 · Common side effects of teduglutide may include: an allergic reaction; stomach pain or swelling; nausea, vomiting; cold or flu symptoms; swelling in your hands …
WebFeb 10, 2024 · GATTEX (teduglutide) for injection is supplied as 5 mg of teduglutide as a white, lyophilized powder for reconstitution in a sterile, single-dose glass vial with 0.5 mL Sterile Water for Injection in a single-dose prefilled syringe. The product to be dispensed is either a one-vial kit or a 30-vial kit. WebIt contains information on Revestive and Teduglutide, which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. This website …
WebREVESTIVE® (teduglutide) Important Safety Information. Please consult the Summary of Product Characteristics (SmPC), before prescribing. Guidance for use Treatment should …
WebJan 25, 2024 · Active Ingredient: semaglutide. Company: Novo Nordisk Limited See contact details. ATC code: A10BJ06. About Medicine. Prescription only medicine. Healthcare Professionals (SmPC) Patient Leaflet (PIL) Live Chat. maria woodruff wrightWebTeduglutide is an analogue of human glucagon-like peptide-2 (GLP-2), which preserves mucosal integrity by promoting growth and repair of the intestine. Indications and dose … maria wood journalistWebSubcutaneous teduglutide is the first long-term medical therapy approved for the treatment of adult patients with SBS who are dependent on parenteral support (parenteral nutrition and/or intravenous fluids). In a pivotal, double-blind, multicentre, phase III study in adult patients with SBS who were dependent on parenteral support, a ... maria wood in union city tnWebAug 9, 2024 · Teduglutide was studied in a 12-week, open-label, clinical study in 42 paediatric subjects aged 1 year through 14 years with SBS who were dependent on … natural healing oils and herbsWebResults: Of 86 patients, 43 each were randomized to teduglutide or placebo (mean age: 51 vs 50 years, respectively). In adjusted analyses, teduglutide had a nonsignificant reduction (improvement) of -8.6 points (95% CI: 2.6 to -19.8) in SBS-QoL sum score from baseline to Week-24 vs placebo. The impact of teduglutide varied by subgroup. maria wood photographymaria woods attorneyWebJun 6, 2013 · Teduglutide does not prolong the QTc interval. Mechanism of action. Teduglutide is an analog of naturally occurring human glucagon-like peptide-2 (GLP-2), a peptide secreted by L-cells of the distal intestine in response to meals. GLP-2 increases intestinal and portal blood flow and inhibit gastric acid secretion. maria wood microsoft